BB-12 EXCELLENCE BY CHR. HANSEN
LIVE

Serial Number

79249164

Owner

CHR. HANSEN A/S

Attorney

Amy Brozenic

Filing Date

Apr 24, 2018

Add to watchlist:

No watchlists yet
View on USPTO

BB-12 EXCELLENCE BY CHR. HANSEN Trademark

Serial Number: 79249164 • Registration: 6044478

BB-12 EXCELLENCE BY CHR. HANSEN is a trademark filed by CHR. HANSEN A/S on April 24, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 32 (Light Beverages). The application is currently registered and active.

Owner Contact Info

CHR. HANSEN A/S (227 trademarks)

BOGE ALLE 10-12
HORSHOLM DK-2970 , DK

Entity Type: 03

Trademark Details

Filing Date

April 24, 2018

Registration Date

May 5, 2020

Published for Opposition

February 18, 2020

Goods & Services

Ingredients for use in fermented milk, cheese and cheese products, namely, fresh milk, full fat milk, buttermilk, condensed milk, whipped cream made from milk, milk beverages consisting principally of milk, flavored milk beverages consisting principally of milk, skyr, kefir, cream, butter, fermented milk, milk ferments for culinary purposes, fermented milk beverages consisting principally of fermented milk, soft cheese, cheese, cottage cheese, ricotta cheese, cream cheese; yoghurt; yoghurt preparations, except for frozen yoghurt, namely, drinking yoghurt, pouring yoghurt, and ingredients for use in yoghurt-based beverages; ingredients for use in beverages based on almonds, soy, coconut, rice, hemp, peanuts, barley, oat, spelt, lupin, peas, cashew nuts, hazel nuts, walnuts, chia seeds, flax seeds, quinoa, sesame seeds, sunflower seeds or hemp seeds being milk and fermented milk substitutes

Bacteriological preparations for medical and veterinary use; bacteriological cultures for use as a food additive for medical purposes; bacteria and preparations of bacteria as well as biological and biochemical preparations for medical use and healthcare; bacteriological cultures for addition to milk, dairy and fermented milk products, for medical purposes; cultures of microorganisms for medical and veterinary purposes; cultures of microorganisms for use in dietary supplements, food supplements, vitamin and mineral preparations; pharmaceutical and veterinary preparations for the prevention of diseases, namely, gastrointestinal and immune health related diseases and urinary tract infections ; dietetic substances in the nature of probiotic dietary supplements adapted for medical use; dietetic nutrients for medical use; dietary supplements; food supplements; vitamin and mineral preparations; food for babies; lactic acid bacterial preparations for medical purposes

Bacteriological preparations other than for medical and veterinary use; bacteriological cultures for addition to food, milk and dairy products, namely, fermented milk products, other than for medical and veterinary purposes; cultures of microorganisms other than for medical and veterinary use; cultures of microorganisms for use in food and beverage manufacture not for medical or veterinary purposes; starter media, namely, bacterial cultures and enzymes for use in cheese manufacture; enzyme preparations for industrial purposes; enzymes for use in the manufacture of milk and dairy products including fermented milk products

Ingredients for use in making mineral and aerated waters and other non-alcoholic drinks in the nature of soft drinks, namely, concentrates, powders; ingredients for use in making berry juices and fruit juices, namely, concentrates, powders; ingredients for use in berry drinks and fruit drinks, namely, concentrates, powders; syrups and other preparations, namely, concentrates, powders, fruit nectars and non-alcoholic fruit extracts for making soft drinks, fruit drinks, fruit juices and non-alcoholic beverages

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 5, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 21, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 3, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 10, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 10, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 5, 2020 FICR
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Jul 23, 2020 CORV
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2020 CRFA
REGISTERED-PRINCIPAL REGISTER
May 5, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 18, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 18, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Feb 14, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 29, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 29, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 29, 2020 NONP
ASSIGNED TO LIE
Jan 14, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 13, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 10, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 4, 2019 GNFN
FINAL REFUSAL E-MAILED
Sep 4, 2019 GNFR
FINAL REFUSAL WRITTEN
Sep 4, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2019 TROA
REFUSAL PROCESSED BY IB
Mar 2, 2019 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2019 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 8, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 8, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 26, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 25, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 18, 2019 MAFR
ASSIGNED TO EXAMINER
Jan 14, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 10, 2019 REPR